Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Erika Maria Grossrubatscher"'
Autor:
Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, Erika Maria Grossrubatscher, Tullio Florio, Francesco Ferraù, Alessandro Veresani, Flaminia Russo, Annamaria Colao, Antongiulio Faggiano
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionMedullary thyroid cancer (MTC) is a rare thyroid tumour whose management in advanced stages is challenging, despite effective therapeutic options having expanded in recent years. Proteasome inhibitors (PrIn) have shown the ability to impr
Externí odkaz:
https://doaj.org/article/36202e21218e4218aff337283e269182
Autor:
Elisa Giannetta, Franz Sesti, Roberta Modica, Erika Maria Grossrubatscher, Valentina Guarnotta, Alberto Ragni, Isabella Zanata, Annamaria Colao, Antongiulio Faggiano
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundHypercalcemia is a common paraneoplastic syndrome which can occur in up to 10% of patients with advanced neoplasms. Paraneoplastic parathyroid hormone-related protein (PTHrP) represents the most frequent cause of this syndrome. In neuroendo
Externí odkaz:
https://doaj.org/article/4b957e4a6f1a4396837c01b920850abf
Autor:
Giuseppina Incampo, Luigi Di Filippo, Erika Maria Grossrubatscher, Paolo Dalino Ciaramella, Stefano Frara, Andrea Giustina, Paola Loli
Publikováno v:
Endocrine. 75:684-697
Adrenal schwannomas (AS) are rare tumours arising from Schwann cells. Due to the high prevalence of adrenal incidentalomas, running into very rare adrenal tumours has become a possibility for high volume expert centres. So far, the clinical behaviour
Autor:
Elisa Giannetta, Franz Sesti, Roberta Modica, Erika Maria Grossrubatscher, Alberto Ragni, Isabella Zanata, Annamaria Colao, Antongiulio Faggiano
Publikováno v:
Journal of Personalized Medicine. 12:1553
Background: Neuroendocrine neoplasms (NEN) originate from neuroendocrine cells ubiquitously spread throughout the body. Hypercalcemia associated with cancer is the most common life-threatening metabolic disorder in patients with advanced stage cancer